WASHINGTON REPORT. A closer look at the recent FDA safety communication about biotin interference.Published in:Medical Laboratory Observer (MLO), 2018, v. 50, n. 3, p. 44By:Wonderling, RamaniPublication type:Article
Lipopolysaccharide-Induced Suppression of Phagocytosis: Effects on the Phagocytic Machinery.Published in:Immunopharmacology & Immunotoxicology, 1996, v. 18, n. 2, p. 267, doi. 10.3109/08923979609052736By:Wonderling, Ramani S.;Ghaffar, Abdul;Mayer, Eugene PPublication type:Article